Web Chapter 35 Canine Papillomaviruses Masahiko Nagata, Tokyo, Japan The papillomavirus (PV) was first described in 1933, when Shope recognized the causative agent responsible for cutaneous papilloma in the cottontail rabbit….
Chapter 151 Respiratory Drug Therapy Eleanor C. Hawkins, Raleigh, North Carolina Mark G. Papich, Raleigh, North Carolina Drugs are the “go to” therapy for respiratory diseases for most clinicians and are the…
Web Chapter 53 Hepatic Support Therapy David C. Twedt, Fort Collins, Colorado Supportive treatment of patients with hepatic disease addresses general pathophysiologic mechanisms common to many hepatic diseases. Although some treatments…
Chapter 118 Superficial Necrolytic Dermatitis Kevin Byrne, Bensalem, Pennsylvania Superficial necrolytic dermatitis (SND) was initially reported in dogs as “diabetic dermatopathy” because of the association of the disorder with diabetes mellitus…
Web Chapter 47 Canine Megaesophagus Beth M. Johnson, Knoxville, Tennessee Robert C. Denovo, Knoxville, Tennessee Erick A. Mears, Tampa, Florida Symptoms of esophageal disease occur when esophageal motility is disturbed or when the…
Chapter 150 Feline Cholangitis David C. Twedt, Fort Collins, Colorado P. Jane Armstrong, St. Paul, Minnesota Kenneth W. Simpson, Ithaca, New York Liver disease is a common clinical finding in the cat. The…
Chapter 149 Feline Hepatic Lipidosis Steve L. Hill, San Diego, California P. Jane Armstrong, St. Paul, Minnesota Hepatic lipidosis (HL) is an intrahepatic cholestatic syndrome resulting from excessive accumulation of lipid within…
Chapter 148 Idiopathic Vacuolar Hepatopathy David C. Twedt, Fort Collins, Colorado Hepatic vacuolar change is a common histologic diagnosis in dogs but not cats. In the author’s review of 150 consecutive…
Chapter 143 Copper Chelator Therapy Allison Bradley, Fort Collins, Colorado David C. Twedt, Fort Collins, Colorado Pathophysiology of Copper-Associated Liver Disease Copper is an essential component of metalloenzymes used in many metabolic…
